AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year Medical Dialogues Bureau18 Aug 2019 4:06 AM GMTA four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
Piramal Enterprises Q1 profit rises 21 percent to Rs 461 crore Medical Dialogues Bureau31 July 2019 3:30 AM GMTPiramal Enterprises said its total loan book grew 20 per cent year-on-year to Rs 56,605 crore. The housing finance loan book, which constitutes 11 per...
Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel Medical Dialogues Bureau28 July 2019 3:47 AM GMTSales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence Meghna A Singhania29 May 2019 9:07 AM GMTNew Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy Garima29 May 2019 4:15 AM GMTSun Pharma said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of...
Medikabazaar to raise Rs 200 crore in Series B funding Garima29 May 2019 4:00 AM GMTThis is being done as part of the Medikabazaar's growth and expansion plans to clock in $100 million in revenues in the financial year 2019-20, he...
Natco Pharma Q4 PAT plunges to Rs 120 crore Garima28 May 2019 4:15 AM GMTThe company's board has declared a third interim dividend of Rs 1.25 per equity share of Rs 2 each, resulting in a total dividend payout of Rs 6.25...
Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report Meghna A Singhania26 May 2019 12:43 PM GMTShanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
Aster DM Healthcare to focus on Expansion in South, West India, to invest Rs 650 crore: Report Farhat Nasim21 Jan 2019 8:43 AM GMT"Our idea is to focus only on tertiary care in cities and we are exploring new facilities in Mumbai, Pune and in Thiruvananthapuram, where we have...
Pharma sector earnings to remain muted in Dec quarter: Edelweiss Securities Ruby Khatun Khatun7 Jan 2018 4:30 AM GMTNew Delhi: Pharma sector's December quarter revenue is estimated to remain flat, while profits are likely to slip owing to decline in US businesses...
Lincoln Pharma gets patent for anti-malarial drug in India Ruby Khatun Khatun20 Dec 2017 6:32 AM GMTNew Delhi: Lincoln Pharmaceuticals has been awarded a patent for an anti-malarial drug in India, the company said.The patent has been awarded by the...
Mallinckrodt dives as sales of main drug Acthar disappoint Ruby Khatun Khatun9 Nov 2017 4:07 AM GMTShares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
